NATALIE AMODEO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CAROL STREAM, IL NPI 1851990667

General Payments — all program years on this page

$1,003.31

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $817.97 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $745.9739
Education $72.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $28.061
2023 $157.287
2024 $817.9740

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086743951 Novartis Pharmaceuticals Corporation $21.31 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086743953 Novartis Pharmaceuticals Corporation $22.32 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104236295 AstraZeneca Pharmaceuticals LP $18.67 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104351334 AstraZeneca Pharmaceuticals LP $19.12 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104474634 AstraZeneca Pharmaceuticals LP $16.76 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104569004 AstraZeneca Pharmaceuticals LP $15.86 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105877667 AstraZeneca Pharmaceuticals LP $18.57 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114265480 Regeneron Healthcare Solutions, Inc. $121.83 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114265482 Regeneron Healthcare Solutions, Inc. $25.72 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114265484 Regeneron Healthcare Solutions, Inc. $9.12 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115809889 GlaxoSmithKline, LLC. $8.20 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115850070 GlaxoSmithKline, LLC. $10.17 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116106085 GlaxoSmithKline, LLC. $1.30 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116121655 GlaxoSmithKline, LLC. $4.36 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116188821 GlaxoSmithKline, LLC. $27.74 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116325278 GlaxoSmithKline, LLC. $11.08 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116373300 GlaxoSmithKline, LLC. $9.93 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116387262 GlaxoSmithKline, LLC. $18.01 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116507085 GlaxoSmithKline, LLC. $4.36 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116542482 GlaxoSmithKline, LLC. $12.82 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116562642 GlaxoSmithKline, LLC. $12.02 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116594016 GlaxoSmithKline, LLC. $26.97 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190001 Amgen Inc. $15.09 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964229 GENZYME CORPORATION $10.14 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964241 GENZYME CORPORATION $2.35 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964245 GENZYME CORPORATION $18.71 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964255 GENZYME CORPORATION $10.97 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964265 GENZYME CORPORATION $3.80 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964267 GENZYME CORPORATION $11.18 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964269 GENZYME CORPORATION $9.85 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964273 GENZYME CORPORATION $10.02 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964277 GENZYME CORPORATION $12.90 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964283 GENZYME CORPORATION $13.40 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964285 GENZYME CORPORATION $8.67 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964287 GENZYME CORPORATION $24.84 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964289 GENZYME CORPORATION $7.90 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964291 SANOFI-AVENTIS U.S. LLC $72.00 11/19/2024 Education Undisputed 01/23/2026 View at CMS
1139964295 GENZYME CORPORATION $16.57 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964297 GENZYME CORPORATION $11.51 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964299 GENZYME CORPORATION $121.83 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.